Abstract
Introduction Survival for children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) has improved remarkably over the past 50 years. While 5-year overall survival (OS) exceeds 85% for newly diagnosed patients, the majority of patients with relapsed and refractory (R/R) T-ALL are not curable (3-year OS
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
